ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0979

The Identification of Shared and Unique Myeloid Cell States in Pre- and Post-nephritic Lupus Mouse Models, Sle.Yaa1 and NZBW

Paul Hoover1, Michael Peters2, David Lieb3, Heather Geiger4, Rakesh Mishra5, Nir Hacohen2 and Anne Davidson6, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Boston, 3Broad Institute, Boston, MA, 4New York Genome Center, New York, NY, 5Feinstein Institute, Manhasset, NY, 6Northwell Health, New York

Meeting: ACR Convergence 2020

Keywords: Dendritic cells, genomics, Lupus nephritis, macrophages, Mouse

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: SLE – Animal Models (0975–0979)

Session Type: Abstract Session

Session Time: 3:00PM-3:50PM

Background/Purpose:

Poor renal prognosis in lupus nephritis (LN) is associated with an abundance of renal macrophages and dendritic cells (DCs) but the role of these cells is not well understood. Because mouse models provide a system for studying the immune response in LN, we characterized the transcriptomes of myeloid cells during pre- and post-nephritic disease in Sle.Yaa1 mice that have an extra copy of TLR7 and NZB/W mice in which an activated adaptive immune system drives disease.

Methods: We sorted PBMCs and dissociated renal cells from pre- and post-nephritic Sle.Yaa1 and NZB/W mice (3-4 per group) using (i) CD45 beads/antibodies to isolate all immune cells or (ii) CD11b/CD11c to enrich for myeloid cells. We performed single cell transcriptomic profiling using 10x genomics and analyzed droplets that contained >500 genes and UMIs after doublet removal. We performed coarse and fine clustering and differential expression (DE) (Seurat v3.0); gene set enrichment; trajectory (analysis Monocle v2.0 and Velcyto); and integration (Harmony). We identified residential vs. infiltrating cells by co-clustering intrarenal with blood data and by using published residential and infiltration gene signatures. We further identified macrophage and DCs subsets by scoring clusters using gene signatures generated from bulk RNASeq of intrarenal myeloid cells sorted by CD11b/CD11c and F4/80 expression.

Results: Several myeloid clusters were identified using data from >5000 cells from each mouse strain. Several novel subclusters of macrophages and DCs were identified in nephritic mice. Macrophages from pre- and post-nephritic mice clustered separately. Trajectory analysis of these cells indicated the acquisition of activation and inflammatory genes in nephritic mice including IL1b, AP1 (Fos and Jun), chemokines, cytoskeleton remodeling genes and polarization towards an alternative phenotype. Loss of Mmp13 and increased Mmp12 expression further suggests acquisition of a profibrotic phenotype. Fcrl5, Fcrg4 patrolling monocytes were found only in nephritic Sle.Yaa1 mice, confirming their expansion in TLR7 overexpressing models. Putative cluster functions were based on the top DE genes and gene set enrichment: macrophages had characteristics of resident cells and were enriched for phagocytosis, lysosomal function and antigen processing/presentation whereas DCs were enriched for transendothelial migration, chemokine signaling and cell adhesion genes, all characteristics of infiltrating cells.  pDCs were enriched in genes in the glycolysis pathway whereas CD103 DCs were highly enriched for genes involved in oxidative phosphorylation.

Conclusion: Resident macrophages are the major myeloid subpopulation in pre-nephritic kidneys in both models and acquire an activated and profibrotic phenotype during nephritis. Post-nephritic kidneys from both models contained novel subclusters of expanded residential and infiltrating macrophages and DCs. Only Sle.Yaa1 kidneys contained patrolling monocytes. These analyses generate new hypotheses about the development of tissue damage in lupus kidney disease and can be used to identify molecular features shared with myeloid cells from human lupus kidneys for targeted follow-up studies.


Disclosure: P. Hoover, None; M. Peters, None; D. Lieb, None; H. Geiger, None; R. Mishra, None; N. Hacohen, None; A. Davidson, None.

To cite this abstract in AMA style:

Hoover P, Peters M, Lieb D, Geiger H, Mishra R, Hacohen N, Davidson A. The Identification of Shared and Unique Myeloid Cell States in Pre- and Post-nephritic Lupus Mouse Models, Sle.Yaa1 and NZBW [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-identification-of-shared-and-unique-myeloid-cell-states-in-pre-and-post-nephritic-lupus-mouse-models-sle-yaa1-and-nzbw/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-identification-of-shared-and-unique-myeloid-cell-states-in-pre-and-post-nephritic-lupus-mouse-models-sle-yaa1-and-nzbw/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology